- How Michael Jung’s team created a drug to extend the lives of men with prostate cancer
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.
March 15, 2018 10:00 AMdetail
- Multimodal approach improves survival in aggressive prostate cancer, study finds
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer. The findings also suggest that such a multimodal treatment approach has the best chance of preventing metastatic disease and improving overall long-term survival.
March 06, 2018 9:00 AMdetail
- Study shows need for early support among people with uveal melanoma
UCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses.
February 22, 2018 8:00 AMdetail
- STOP CANCER sunsets operation with $700,000 gift to UCLA Jonsson Comprehensive Cancer Center
UCLA will receive a $700,000 gift from STOP CANCER in support of the UCLA Jonsson Comprehensive Cancer Center and its researchers, providing critical funds to advance the university’s efforts in cancer research, education and treatment.
February 01, 2018 6:30 AMdetail
- Researchers link a relatively unknown gene to early emergence of blood diseases
UCLA researchers, in collaboration with the University of Iowa, discovered the contribution of a specific gene in the proper development of blood cells that give rise to hematopoietic stem cells. The findings identify a potential target for the development of treatments for some types of leukemia, anemia and other blood disorders.
January 31, 2018 9:00 AMdetail
- UCLA scientists use stem cells to study rare group of cancers that begin in germ cells
UCLA researchers have made new inroads into understanding germ cell tumors, a diverse and rare group of cancers that begin in germ cells — the cells that develop into sperm and eggs.
January 30, 2018 10:00 AMdetail
- With $3.1M grant from NIH, UCLA scientists to advance adoption of focal therapy to treat prostate cancer
UCLA researchers Dr. Leonard Marks and Shyam Natarajan will lead a $3.1 million research project grant awarded by the National Institutes of Health to advance the adoption of a promising new technology to treat men with prostate cancer.
January 26, 2018 10:00 AMdetail
- UCLA scientist receives prestigious grant to advance gastroenterology cancer research
Dr. Zev Wainberg, an associate professor of medicine at the David Geffen School of Medicine and co-director of the UCLA Gastrointestinal Oncology Program, has been awarded the 2018 Fishman Family Seed Grant in memory of Martin Fishman by STOP CANCER.
January 17, 2018 10:00 AMdetail
- Immunotherapy highly effective in treatment of rare skin cancer, study finds
In a UCLA-led study, more than two-thirds of people with a rare type of melanoma responded positively to treatment with anti-PD-1 immunotherapies.
January 10, 2018 6:00 AMdetail
- Dao moves on
While battling brain cancer under the care of UCLA Jonsson Comprehensive Cancer Center physician-scientist Dr. PhiOanh NghiemPhu, an old poet packs up his house and learns about finding peace in letting go.
December 22, 2017 10:00 AMdetail